Hill-Rom Holdings has received 510(k) clearance from the FDA to market its latest advancement in airway clearance technology, the MetaNeb 4.0.
The MetaNeb 4.0 system uses continuous high frequency oscillation and continuous positive expiratory pressure to enhance normal mucus clearance from the lungs, deliver lung expansion therapy, and assist in the treatment and prevention of pulmonary atelectasis (a complete or partial collapse of the lung), according to Hill-Rom. The device can also provide supplemental oxygen when used with compressed oxygen.
"The design enhancements to the MetaNeb System represent another great example of Hill-Rom's dedication to improving outcomes for patients and their caregivers," said Greg Pritchard, Senior Vice President, Surgical and Respiratory Care, for Hill-Rom. "Together with The Vest® Airway Clearance System, our Respiratory Care portfolio now offers complementary innovative solutions for patients with respiratory disorders."
The device is designed to treat patients with bronchiolitis, cystic fibrosis, asthma, chronic bronchitis, neuromuscular disorders, emphysema and COPD, as well as for ER and post-operative patients, according to Hill-Rom.